BRIEF published on 07/25/2025 at 08:50, 8 months 20 days ago Adocia and Tonghua Dongbao Report Phase 3 Success for Ultra-Rapid Insulin Diabetes Treatment Clinical Trial Phase 3 Results ADOCIA BioChaperone® Lispro
PRESS RELEASE published on 07/25/2025 at 08:45, 8 months 20 days ago Informations privilégiées / Autres communiqués ADOCIA et Tonghua Dongbao annoncent des résultats positifs de l'essai clinique de Phase 3 sur l'insuline ultra-rapide BioChaperone® Lispro pour le diabète de Type 2 en Chine Essai Clinique Diabète De Type 2 ADOCIA Tonghua Dongbao Insuline Ultra-rapide
PRESS RELEASE published on 07/25/2025 at 08:45, 8 months 20 days ago Inside Information / Other news releases Adocia and Tonghua Dongbao announce positive Phase 3 results of Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in Type 2 Diabetes. Significant HbA1c reduction and improved post-meal blood glucose levels compared to Humalog® Type 2 Diabetes Phase 3 Results ADOCIA Tonghua Dongbao Ultra-Rapid Insulin
BRIEF published on 04/04/2025 at 11:21, 1 year ago Vester Finance réduit sa participation dans ADOCIA Droits De Vote Franchissement De Seuil Actions ADOCIA Vester Finance
BRIEF published on 04/04/2025 at 11:21, 1 year ago Vester Finance reduces its stake in ADOCIA Voting Rights Actions Threshold Crossing ADOCIA Vester Finance
PRESS RELEASE published on 04/04/2025 at 11:16, 1 year ago Franchissement de seuil Déclaration de franchissement de seuil par Vester Finance pour 9,82% du capital de ADOCIA Franchissement De Seuil Marché ADOCIA Vester Finance 10%
BRIEF published on 02/28/2025 at 19:33, 1 year 1 month ago Adocia finalise un placement privé de 9,7 millions d'euros Capital Social Placement Privé Biopharmaceutique Traitement Du Diabète ADOCIA
BRIEF published on 02/28/2025 at 19:33, 1 year 1 month ago Adocia Completes €9.7 Million Private Placement Private Placement Share Capital Biopharmaceutical Diabetes Treatment ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 1 month ago Informations privilégiées / Autres communiqués Adocia annonce le règlement-livraison de son placement privé de 9,7 millions d'euros, avec émission d'actions nouvelles et bons de souscription d'actions Placement Privé Biopharmaceutique Actions Nouvelles Bons De Souscription ADOCIA
PRESS RELEASE published on 02/28/2025 at 19:28, 1 year 1 month ago Inside Information / Other news releases Adocia successfully settles and delivers €9.7 million private placement, issuing 2,125,000 new ordinary shares with warrants. Admittance to trading on Euronext Paris confirmed Private Placement Euronext Paris Diabetes Biopharmaceutical ADOCIA
Published on 04/14/2026 at 15:05, 1 hour 11 minutes ago Karbon-X Expands Canadian Compliance Offering as Regulatory Deadlines Approach Across Federal and Provincial Carbon Markets
Published on 04/14/2026 at 15:00, 1 hour 16 minutes ago Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Published on 04/14/2026 at 14:55, 1 hour 21 minutes ago BEACN Introduces Voice-First Headset as It Expands Its Creator Audio Platform
Published on 04/14/2026 at 14:30, 1 hour 46 minutes ago Goldcliff Extends Kettle Valley Drill Permit to 2028 and Completes Trench Program Advancing North Cliff Zone Targets
Published on 04/14/2026 at 14:30, 1 hour 46 minutes ago Core Critical Metals Corp. Announces Closing of the Option for the Lucky Mike Silver-Copper-Tungsten Project
Published on 04/14/2026 at 16:00, 16 minutes ago Open-air driving pleasure in the new Porsche 911 GT3 S/C
Published on 04/14/2026 at 15:18, 58 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 04/14/2026 at 15:16, 1 hour ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 04/14/2026 at 08:30, 7 hours 46 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 21 hours 1 minute ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 22 hours 1 minute ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 22 hours 1 minute ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 22 hours 7 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.
